JP2009502355A5 - - Google Patents

Download PDF

Info

Publication number
JP2009502355A5
JP2009502355A5 JP2008524219A JP2008524219A JP2009502355A5 JP 2009502355 A5 JP2009502355 A5 JP 2009502355A5 JP 2008524219 A JP2008524219 A JP 2008524219A JP 2008524219 A JP2008524219 A JP 2008524219A JP 2009502355 A5 JP2009502355 A5 JP 2009502355A5
Authority
JP
Japan
Prior art keywords
random copolymer
acrylamide
methyl
propane sulfonate
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008524219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009502355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/029555 external-priority patent/WO2007016405A2/en
Publication of JP2009502355A publication Critical patent/JP2009502355A/ja
Publication of JP2009502355A5 publication Critical patent/JP2009502355A5/ja
Pending legal-status Critical Current

Links

JP2008524219A 2005-07-29 2006-07-27 制御された活性薬剤放出又は血液適合性のための、装置、製品、コーティング及び方法 Pending JP2009502355A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70355505P 2005-07-29 2005-07-29
US73342305P 2005-11-03 2005-11-03
PCT/US2006/029555 WO2007016405A2 (en) 2005-07-29 2006-07-27 Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility

Publications (2)

Publication Number Publication Date
JP2009502355A JP2009502355A (ja) 2009-01-29
JP2009502355A5 true JP2009502355A5 (enExample) 2009-09-10

Family

ID=37709234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008524219A Pending JP2009502355A (ja) 2005-07-29 2006-07-27 制御された活性薬剤放出又は血液適合性のための、装置、製品、コーティング及び方法

Country Status (5)

Country Link
US (1) US8663673B2 (enExample)
EP (1) EP1912684B1 (enExample)
JP (1) JP2009502355A (enExample)
CA (1) CA2616959A1 (enExample)
WO (1) WO2007016405A2 (enExample)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US20070212397A1 (en) * 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
WO2008003043A2 (en) * 2006-06-28 2008-01-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
US8685421B2 (en) * 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
WO2008022258A2 (en) * 2006-08-16 2008-02-21 Surmodics, Inc. Methods and materials for increasing the adhesion of elution control matrices to substrates
US20080075753A1 (en) * 2006-09-25 2008-03-27 Chappa Ralph A Multi-layered coatings and methods for controlling elution of active agents
US20080075779A1 (en) * 2006-09-27 2008-03-27 Chappa Ralph A Additives And Methods For Enhancing Active Agent Elution Kinetics
EP2091584A2 (en) * 2006-12-12 2009-08-26 Bausch & Lomb Incorporated Ordered polymer system and intraocular lens
US8182829B2 (en) * 2007-07-27 2012-05-22 Abbott Cardiovascular Systems Inc. Drug eluting implantable medical device with hemocompatible and/or prohealing topcoat
TR201820076T4 (tr) * 2007-08-16 2019-01-21 Biocompatibles Uk Ltd İlaç kombinasyonlarının salımı.
US20090214601A1 (en) * 2007-09-28 2009-08-27 Chappa Ralph A Porous Drug Delivery Devices and Related Methods
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
EP2242520A2 (en) * 2008-01-14 2010-10-27 SurModics, Inc. Devices and methods for elution of nucleic acid delivery complexes
WO2009126830A2 (en) * 2008-04-09 2009-10-15 Surmodics, Inc. Delivery of nucleic acid complexes from materials including negatively charged groups
CA2723192A1 (en) * 2008-05-07 2009-11-12 Surmodics, Inc. Delivery of nucleic acid complexes from particles
EP2306929A1 (en) * 2008-07-14 2011-04-13 SurModics, Inc. Medical devices and methods for delivery of nucleic acids
DE102008038368A1 (de) * 2008-08-19 2010-02-25 Biotronik Vi Patent Ag Verwendung von organischen Gold-Komplexen als bioaktive und radioopaque Stentbeschichtung für permanente und degradierbare vaskuläre Implantate
CA3045436C (en) 2009-01-29 2025-10-07 Forsight Vision4, Inc. ADMINISTRATION OF A MEDICATION IN THE POSTERIOR SEGMENT
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
WO2010118238A2 (en) * 2009-04-08 2010-10-14 Surmodics, Inc. Controlled release devices and methods for delivery of nucleic acids
US8883208B2 (en) * 2009-04-08 2014-11-11 Surmodics, Inc. Particles for delivery of nucleic acids and related devices and methods
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US8246576B2 (en) 2009-05-18 2012-08-21 Surmodics, Inc. Method and apparatus for delivery of a therapeutic agent with an expandable medical device
JP5937004B2 (ja) 2009-05-18 2016-06-22 ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 薬剤溶出眼内インプラント
US10166142B2 (en) 2010-01-29 2019-01-01 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
JP6075732B2 (ja) 2010-04-13 2017-02-08 ケーシーアイ ライセンシング インク 反応性成分を含む組成物ならびに創傷被覆材、装置および方法
US20110319473A1 (en) 2010-06-29 2011-12-29 Surmodics, Inc. Compositions and methods for enhancement of nucleic acid delivery
CN103209664A (zh) 2010-08-05 2013-07-17 弗赛特影像4股份有限公司 可植入的治疗装置
CN103153316B (zh) 2010-08-05 2015-08-19 弗赛特影像4股份有限公司 组合药物递送方法和设备
WO2012019136A2 (en) 2010-08-05 2012-02-09 Forsight Vision 4, Inc. Injector apparatus and method for drug delivery
AU2011329656B2 (en) 2010-11-19 2017-01-05 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
US20130041203A1 (en) * 2011-02-18 2013-02-14 Marlin Stephen Heilman Blood flow assist devices, systems and methods
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
US9120040B2 (en) * 2011-05-26 2015-09-01 The University Of Akron Anti-fouling materials based on poly(β-peptoid)s
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
EP2726016B1 (en) 2011-06-28 2023-07-19 ForSight Vision4, Inc. An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
SI2755600T1 (sl) 2011-09-16 2021-08-31 Forsight Vision4, Inc. Naprava za izmenjavo tekočine
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス，インコーポレイテッド 創傷充填デバイスおよび方法
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
US9555119B2 (en) 2012-11-05 2017-01-31 Surmodics, Inc. Composition and method for delivery of hydrophobic active agents
AU2014236455B2 (en) 2013-03-14 2018-07-12 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
AU2014241163B2 (en) 2013-03-28 2018-09-27 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
US20150342875A1 (en) 2014-05-29 2015-12-03 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
RU2695563C2 (ru) 2014-07-15 2019-07-24 Форсайт Вижн4, Инк. Способ и устройство для доставки глазного имплантата
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
MY182793A (en) 2014-08-08 2021-02-05 Forsight Vision4 Inc Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
JP7037360B2 (ja) 2014-11-10 2022-03-16 フォーサイト・ビジョン フォー・インコーポレーテッド 拡張可能な薬物送達デバイス
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
CN113384390B (zh) 2015-09-15 2023-08-22 萨维奇医疗股份有限公司 用于在组织腔中锚定护套的装置和方法
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
KR20180084104A (ko) 2015-11-20 2018-07-24 포사이트 비젼4, 인크. 연장 방출 약물 전달 장치를 위한 다공성 구조물
BR112018070383A2 (pt) 2016-04-05 2019-02-05 Forsight Vision4 Inc dispositivos para aplicação de fármaco oculares implantáveis
US11318043B2 (en) 2016-04-20 2022-05-03 Dose Medical Corporation Bioresorbable ocular drug delivery device
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
CN115607358A (zh) 2017-11-21 2023-01-17 弗赛特影像4股份有限公司 用于可扩展端口递送系统的流体交换装置及使用方法
US12226552B2 (en) 2019-09-30 2025-02-18 Surmodics, Inc. Active agent depots formed in situ
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4638045A (en) 1985-02-19 1987-01-20 Massachusetts Institute Of Technology Non-peptide polyamino acid bioerodible polymers
DE69231073T2 (de) * 1991-10-24 2001-02-15 Insutech, Inc. Durch mittels elektrolyse in hydrogel erzeugten gasdruck angetriebenes infusionssystem
JP3455217B2 (ja) 1992-02-13 2003-10-14 バイオ−メトリック システムズ インコーポレイテッド 架橋マトリックス中の化学種の固定
US5344455A (en) 1992-10-30 1994-09-06 Medtronic, Inc. Graft polymer articles having bioactive surfaces
US5788687A (en) 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5466233A (en) 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US5840387A (en) 1995-07-28 1998-11-24 Aegis Biosciences L.L.C. Sulfonated multiblock copolymer and uses therefor
US6110483A (en) 1997-06-23 2000-08-29 Sts Biopolymers, Inc. Adherent, flexible hydrogel and medicated coatings
US5928783A (en) 1998-03-09 1999-07-27 National Starch And Chemical Investment Holding Corporation Pressure sensitive adhesive compositions
US20020188037A1 (en) 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
AU760408B2 (en) 1998-04-27 2003-05-15 Surmodics, Inc. Bioactive agent release coating
CA2356751A1 (en) 1998-12-30 2000-07-13 The B.F. Goodrich Company Branched/block copolymers for treatment of keratinous substrates
EP1026219A1 (en) * 1999-02-02 2000-08-09 First Water Limited Bioadhesive compositions
US6306419B1 (en) 2000-02-23 2001-10-23 Aegis Biosciences, Llc Medical uses of styrene sulfonate polymers
EP1280860A2 (en) 2000-05-04 2003-02-05 Kimberly-Clark Worldwide, Inc. Salt-sensitive, water-dispersible polymer composition
JP2004520088A (ja) 2000-08-15 2004-07-08 サーモディックス，インコーポレイティド 薬剤混和マトリックス
ATE404140T1 (de) 2000-08-30 2008-08-15 Univ Johns Hopkins Vorrichtung zur intraokularen wirkstoffverabreichung
JP4677538B2 (ja) 2001-06-12 2011-04-27 ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン 眼内薬物送達のためのリザーバデバイス
EP1434571B1 (en) 2001-10-05 2005-05-11 SurModics, Inc. Particle immobilized coatings and uses thereof
CA2689424A1 (en) 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
US20040142910A1 (en) 2002-10-21 2004-07-22 Aegis Biosciences Llc Sulfonated styrene copolymers for medical uses
ATE476960T1 (de) 2003-05-02 2010-08-15 Surmodics Inc System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges
US20060240065A1 (en) 2005-04-26 2006-10-26 Yung-Ming Chen Compositions for medical devices containing agent combinations in controlled volumes
US20060110428A1 (en) 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
US7771740B2 (en) * 2004-07-19 2010-08-10 Boston Scientific Scimed, Inc. Medical devices containing copolymers with graft copolymer endblocks for drug delivery
US20060251824A1 (en) 2005-05-05 2006-11-09 Boulais Dennis R Coating of medical devices with solids

Similar Documents

Publication Publication Date Title
AU2015315108B2 (en) Antimicrobial and biologically active polymer composites and related methods, materials and devices
Namivandi-Zangeneh et al. Nitric oxide-loaded antimicrobial polymer for the synergistic eradication of bacterial biofilm
ES2210808T3 (es) Composiciones y su uso para prevenir la formacion de adherencias en un tejido biologico.
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
JP2019515908A5 (enExample)
JP2011528713A5 (enExample)
RU2010153904A (ru) Ниацин-содержащие композиции с модифицированным высвобождением
EP2591804A3 (en) Polymer nanoparticles coated by magnetic metal oxide and uses thereof
BRPI0414017A (pt) pró-fármacos poliméricos de múltiplos braços
JP2011505377A5 (enExample)
NZ595663A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
JP6961587B2 (ja) 滑り性付与剤および滑り性付与方法
RU2011136636A (ru) Фармацевтическая композиция для орального введения
JP2004535430A5 (enExample)
JP2006502166A5 (enExample)
JP2011225596A5 (enExample)
JP2016539156A5 (enExample)
RU2005126412A (ru) Сор1 для лечения воспалительных заболеваний кишечника
TW200815410A (en) Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
RU2016130161A (ru) Покрытия для медицинских изделий
RU2013112807A (ru) Композиция для доставки активных агентов в желудок
JP2010521516A5 (enExample)
BG106602A (en) Formulation of substituted benzimidazoles
JP2009510165A5 (enExample)
CA2565993A1 (en) Salt of 4-or 5- aminosalicylic acid